Adagene (ADAG) Short Interest Ratio & Short Volume $1.99 -0.01 (-0.50%) As of 11:27 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Adagene Short Interest DataAdagene (ADAG) has a short interest of 43,700 shares, representing 0.12% of the float (the number of shares available for trading by the public). This marks a 320.19% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.4, indicating that it would take 0.4 days of the average trading volume of 70,698 shares to cover all short positions.Current Short Interest43,700 sharesPrevious Short Interest10,400 sharesChange Vs. Previous Month+320.19%Dollar Volume Sold Short$92.21 thousandShort Interest Ratio0.4 Days to CoverLast Record DateSeptember 15, 2025Outstanding Shares47,130,000 sharesFloat Size36,740,000 sharesShort Percent of Float0.12%Today's Trading Volume95,484 sharesAverage Trading Volume70,698 sharesToday's Volume Vs. Average135% Short Selling Adagene? Sign up to receive the latest short interest report for Adagene and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartADAG Short Interest Over TimeADAG Days to Cover Over TimeADAG Percentage of Float Shorted Over Time Adagene Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 9/15/202543,700 shares $92.21 thousand +320.2%0.1%0.4 $2.11 8/31/202510,400 shares $22.15 thousand -38.1%0.0%0.1 $2.13 8/15/202516,800 shares $28.39 thousand -70.6%0.1%0.2 $1.69 7/31/202557,100 shares $113.63 thousand -6.6%0.2%0.8 $1.99 7/15/202561,100 shares $116.09 thousand -20.9%0.2%0.9 $1.90 6/30/202577,200 shares $150.54 thousand -12.7%0.2%1.7 $1.95 6/15/202588,400 shares $172.38 thousand +28.1%0.3%2.2 $1.95 5/31/202569,000 shares $133.86 thousand -9.9%0.2%2.1 $1.94 5/15/202576,600 shares $135.58 thousand +94.4%0.2%2.8 $1.77 4/30/202539,400 shares $59.89 thousand -17.4%0.1%1.4 $1.52 Get the Latest News and Ratings for ADAG and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Adagene and its competitors with MarketBeat's FREE daily newsletter. 4/15/202547,700 shares $76.32 thousand -28.7%0.1%0.7 $1.60 3/31/202566,900 shares $102.69 thousand +265.6%0.2%1 $1.54 3/15/202518,300 shares $32.42 thousand +3.4%0.1%0.3 $1.77 2/28/202517,700 shares $35.58 thousand -55.9%0.1%0.2 $2.01 2/15/202540,100 shares $70.58 thousand +13.3%0.1%0.5 $1.76 1/31/202535,400 shares $67.26 thousand -50.2%0.1%0.4 $1.90 1/15/202571,100 shares $131.18 thousand -10.7%0.2%0.7 $1.85 12/31/202479,600 shares $158.40 thousand +21.9%0.2%1.3 $1.99 12/15/202465,300 shares $134.52 thousand +88.2%0.2%1.1 $2.06 11/30/202434,700 shares $81.02 thousand +2,213.3%0.1%0.5 $2.34 11/15/20241,500 shares $3.24 thousand -87.8%N/A0 $2.16 10/31/202412,300 shares $35.06 thousand -42.5%0.0%0.1 $2.85 10/15/202421,400 shares $51.15 thousand -30.7%0.1%0.3 $2.39 9/30/202430,900 shares $68.60 thousand +153.3%0.1%0.4 $2.22 9/15/202412,200 shares $42.58 thousand -2.4%0.0%0.2 $3.49 8/31/202412,500 shares $35 thousand -3.9%0.0%0.2 $2.80 8/15/202413,000 shares $33.67 thousand +170.8%0.0%0.3 $2.59 7/31/20244,800 shares $11.71 thousand -34.3%0.0%0.2 $2.44 7/15/20247,300 shares $19.93 thousand -62.9%0.0%0.2 $2.73 6/30/202419,700 shares $60.30 thousand +45.9%0.1%0.6 $3.06 6/15/202413,500 shares $36.18 thousand +400.0%0.0%0.4 $2.68 5/31/20242,700 shares $6.83 thousand -75.7%0.0%0.1 $2.53 5/15/202411,100 shares $29.53 thousand -26.5%0.0%0.3 $2.66 4/30/202415,100 shares $34.13 thousand +6.3%0.0%0.6 $2.26 4/15/202414,200 shares $36.92 thousand +3.7%0.0%0.3 $2.60 3/31/202413,700 shares $38.36 thousand -38.6%0.0%0.1 $2.80 3/15/202422,300 shares $63.44 thousand +9.9%0.1%0.2 $2.85 2/29/202420,300 shares $64.96 thousand -7.3%0.1%0.2 $3.20 2/15/202421,900 shares $76.65 thousand -50.9%0.1%0.2 $3.50 1/31/202444,600 shares $163.24 thousand +105.5%0.1%0.4 $3.66 1/15/202421,700 shares $68.79 thousand -13.9%0.1%0.2 $3.17 12/31/202325,200 shares $48.67 thousand -23.2%0.1%0.8 $1.93 12/15/202332,800 shares $50.18 thousand +47.8%0.1%1.5 $1.53 11/30/202322,200 shares $38.85 thousand +0.5%0.1%1.2 $1.75 11/15/202322,100 shares $30.06 thousand +0.9%0.1%1.5 $1.36 10/31/202321,900 shares $29.67 thousand -9.5%0.1%1.4 $1.36 10/15/202324,200 shares $34.12 thousand -4.0%0.1%1.4 $1.41 9/30/202325,200 shares $38.56 thousand +0.4%0.1%1.4 $1.53 9/15/202325,100 shares $35.64 thousand -14.0%0.1%1.1 $1.42 8/31/202329,200 shares $39.71 thousand +4.3%0.1%1.1 $1.36 8/15/202328,000 shares $37.24 thousand +42.1%0.1%1.1 $1.33 7/31/202319,700 shares $26.79 thousand +8.2%0.1%0.8 $1.36 7/15/202318,200 shares $26.57 thousand -34.1%0.0%0.7 $1.46 6/30/202327,600 shares $39.19 thousand +200.0%0.1%1.1 $1.42 6/15/20239,200 shares $12.70 thousand -48.9%0.0%0.6 $1.38 5/31/202318,000 shares $24.12 thousand -8.2%0.0%1.6 $1.34 5/15/202319,600 shares $26.07 thousand +108.5%0.1%1.8 $1.33 4/30/20239,400 shares $12.31 thousand -9.6%0.0%0.8 $1.31 4/15/202310,400 shares $15.50 thousand -28.8%0.0%0.7 $1.49 3/31/202314,600 shares $21.17 thousand +44.6%0.0%0.7 $1.45 3/15/202310,100 shares $16.16 thousand +23.2%0.0%0.4 $1.60 2/28/20238,200 shares $13.64 thousand -10.9%0.0%0.2 $1.66 2/15/20239,200 shares $17.34 thousand -24.0%0.0%0.2 $1.89 1/31/202312,100 shares $23.23 thousand -38.3%0.0%0.2 $1.92 1/15/202319,600 shares $34.89 thousand -59.9%0.1%0.3 $1.78 12/30/202248,900 shares $64.79 thousand -63.9%0.1%0.7 $1.33 12/15/2022135,300 shares $178.60 thousand +30.9%0.3%2 $1.32 11/30/2022103,400 shares $111.67 thousand -7.2%0.3%1.8 $1.08 11/15/2022111,400 shares $132.57 thousand +17.8%0.3%2 $1.19 10/31/202294,600 shares $85.14 thousand +56.6%0.2%1.5 $0.90 10/15/202260,400 shares $79.12 thousand -5.0%0.2%1.2 $1.31 9/30/202263,600 shares $81.41 thousand +8.7%0.2%1.3 $1.28 9/15/202258,500 shares $83.07 thousand -9.3%0.1%0.8 $1.42 8/31/202264,500 shares $94.17 thousand -21.2%0.2%0.7 $1.46 8/15/202281,800 shares $114.52 thousand +19.9%0.2%0.9 $1.40 7/31/202268,200 shares $115.26 thousand -4.2%0.2%0.9 $1.69 7/15/202271,200 shares $137.77 thousand +37.7%0.2%1.1 $1.94 6/30/202251,700 shares $107.02 thousand -4.3%0.1%0.8 $2.07 6/15/202254,000 shares $108 thousand -13.7%0.1%1.1 $2.00 5/31/202262,600 shares $175.28 thousand -18.0%0.2%1.9 $2.80 5/15/202276,300 shares $243.40 thousand -3.4%0.2%1.9 $3.19 4/30/202279,000 shares $288.35 thousand -2.8%0.2%2.1 $3.65 4/15/202281,300 shares $301.62 thousand +6.4%0.2%2.2 $3.71 3/31/202276,400 shares $267.40 thousand -11.5%0.2%2.2 $3.50 3/15/202286,300 shares $418.56 thousand -0.9%0.2%3 $4.85 2/28/202287,100 shares $473.82 thousand -1.8%0.2%3.4 $5.44 2/15/202288,700 shares $584.91 thousand -9.8%0.2%4.7 $6.59 1/31/202298,300 shares $711.69 thousand +7.3%0.2%4.9 $7.24 1/15/202291,600 shares $749.75 thousand +5.8%0.2%4.6 $8.19 12/31/202186,600 shares $698.72 thousand -23.3%0.2%4 $8.07 12/15/2021112,900 shares $1.01 million -20.3%0.3%5.1 $8.99 11/30/2021141,600 shares $1.16 million -1.3%0.4%6.2 $8.22 11/15/2021143,500 shares $1.48 million -3.4%0.4%7 $10.29 10/29/2021148,500 shares $1.67 million -27.5%0.4%7.4 $11.24 10/15/2021204,700 shares $2.39 million -4.3%0.5%8 $11.70 9/30/2021213,900 shares $3.07 million +18.2%0.5%6.6 $14.37 9/15/2021180,900 shares $2.76 million -28.6%0.4%4.8 $15.25 8/31/2021253,500 shares $4.10 million -17.5%0.6%7.1 $16.16 8/13/2021307,100 shares $5.68 million No Change0.7%6.3 $18.50 ADAG Short Interest - Frequently Asked Questions What is Adagene's current short interest? Short interest is the volume of Adagene shares that have been sold short but have not yet been covered or closed out. As of September 15th, investors have sold 43,700 shares of ADAG short. 0.12% of Adagene's shares are currently sold short. Learn More on Adagene's current short interest. What is a good short interest percentage for Adagene? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.12% of Adagene's floating shares are currently sold short. Is Adagene's short interest increasing or decreasing? Adagene saw a increase in short interest in September. As of September 15th, there was short interest totaling 43,700 shares, an increase of 320.2% from the previous total of 10,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Adagene's float size? Adagene currently has issued a total of 47,130,000 shares. Some of Adagene's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Adagene currently has a public float of 36,740,000 shares. How does Adagene's short interest compare to its competitors? 0.12% of Adagene's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Adagene: Immuneering Corporation (9.95%), ADC Therapeutics SA (3.62%), Aura Biosciences, Inc. (7.03%), Bright Minds Biosciences Inc. (4.06%), Cullinan Therapeutics, Inc. (17.03%), Tvardi Therapeutics, Inc. (10.96%), Autolus Therapeutics PLC Sponsored ADR (3.99%), Benitec Biopharma Limited (4.99%), DiaMedica Therapeutics, Inc. (7.97%), Contineum Therapeutics, Inc. (5.61%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Corporation ($8.81 billion), Canadian Natural Resources Limited ($5.82 billion), Reddit Inc. ($5.19 billion), Coinbase Global, Inc. ($4.52 billion), Robinhood Markets, Inc. ($4.30 billion), Charter Communications, Inc. ($3.75 billion), CoreWeave Inc. ($3.66 billion), Seagate Technology Holdings PLC ($3.57 billion), Live Nation Entertainment, Inc. ($3.33 billion), and Rocket Lab Corporation ($3.26 billion). View all of the most shorted stocks. What does it mean to sell short Adagene stock? Short selling ADAG is an investing strategy that aims to generate trading profit from Adagene as its price is falling. ADAG shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Adagene? A short squeeze for Adagene occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ADAG, which in turn drives the price of the stock up even further. How often is Adagene's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ADAG, twice per month. The most recent reporting period available is September, 15 2025. More Short Interest Resources from MarketBeat Related Companies Immuneering Short Squeeze ADC Therapeutics Short Squeeze Aura Biosciences Short Squeeze Bright Minds Biosciences Short Squeeze Cullinan Therapeutics Short Squeeze Tvardi Therapeutics Short Squeeze Autolus Therapeutics Short Squeeze Benitec Biopharma Short Squeeze DiaMedica Therapeutics Short Squeeze Contineum Therapeutics Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ADAG) was last updated on 10/2/2025 by MarketBeat.com Staff From Our PartnersThe Army Just Got a New Drone SupplierThis innovative drone developer has been selected to supply its Flex FPV Modular Drones to the U.S. Army. T...The Tomorrow Investor | SponsoredExpert Alert: Massive Bubble Could Crash Your WealthOn July 4th, Trump signed the “One Big Beautiful Bill,” adding $3.4 trillion to the national debt — and pushin...American Alternative | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredThis Biotech has a clinical approach that intrigues investorsThis biotech is gearing up for Phase 2 trials with a strategy to unlock multiple approvals from one study. ...i2i Marketing Group, LLC | SponsoredFree: The Crypto Summit That Could Change Your LifeFed cuts unleash crypto's next wave The smart money is already moving. This is your chance to see their car...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adagene Inc. Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Adagene With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
